Enhanced dereplication of fungal cultures via use of mass defect filtering

Journal of Antibiotics

Volumn 70, Issue 5, 2017, Pages 553-561

  Paguigan, Noemi D ^a   El Elimat, Tamam ^a   Kao, Diana ^a   Raja, Huzefa A ^a   Pearce, Cedric J ^b   Oberlies, Nicholas H ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b Mycosynthetix   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL EXTRACT; BIOLOGICAL PRODUCT;

ARTICLE; ELECTROSPRAY; FILTRATION; FUNGUS CULTURE; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RETENTION TIME; TANDEM MASS SPECTROMETRY; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; DRUG DEVELOPMENT; ELECTROSPRAY MASS SPECTROMETRY; FACTUAL DATABASE; FUNGUS; METABOLISM; PROCEDURES; SECONDARY METABOLISM; TIME FACTOR;

BIOLOGICAL PRODUCTS; CHROMATOGRAPHY, LIQUID; DATABASES, FACTUAL; DRUG DISCOVERY; FUNGI; SECONDARY METABOLISM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 85014735277     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2016.145     Document Type: Article

References (48)

1. Burg, R. W. et al. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents Chemother. 15, 361-367 (1979).
2. Egerton, J. R. et al. Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrob. Agents Chemother. 15, 372-378 (1979).
3. Campbell, W. C., Burg, R. W., Fisher, M. H., Dybas, R. A. in Pesticide Synthesis Through Rational Approaches. The Discovery of Ivermectin and Other Avermectins (eds Magee P. S., Kohn G. K. & Menn J. J.) 5-20 (American Chemical Society, 1984).
4. Newman, D. J. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629-661 (2016).
5. Cragg, G. M. & Newman, D. J. Natural products: a continuuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670-3695 (2013).
6. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335 (2012).
7. Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111-129 (2015).
8. Hubert, J., Nuzillard, J.-M. & Renault, J.-H. Dereplication strategies in natural product research: how many tools and methodologies behind the same concept? Phytochem. Rev. 15, 1-41 (2015).
9. Gaudencio, S. P. & Pereira, F. Dereplication: racing to speed up the natural products discovery process. Nat. Prod. Rep. 32, 779-810 (2015).
10. Ito, T. & Masubuchi, M. Dereplication of microbial extracts and related analytical technologies. J. Antibiot. 67, 353-360 (2014).
11. Kellogg, J. J. et al. Biochemometrics for natural products research: comparison of data analysis approaches and application to identification of bioactive compounds. J. Nat. Prod. 79, 376-386 (2016).
12. Wolfender, J.-L., Marti, G., Thomas, A. & Bertrand, S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 1382, 136-164 (2015).
13. Ernst, M., Silva, D. B., Silva, R. R., Vencio, R. Z. N. & Lopes, N. P. Mass spectrometry in plant metabolomics strategies: from analytical platforms to data acquisition and processing. Nat. Prod. Rep. 31, 784-806 (2014).
14. Tchoumtchoua, J., Njamen, D., Mbanya, J. C., Skaltsounis, A. L. & Halabalaki, M. Structure-oriented UHPLC-LTQ Orbitrap-based approach as a dereplication strategy for the identification of isoflavonoids from Amphimas pterocarpoides crude extract. J. Mass Spectrom. 48, 561-575 (2013).
15. Kinghorn, A. D. Discovery of anticancer agents of diverse natural origin. Pure Appl. Chem. 81, 1051-1063 (2009).
16. El-Elimat, T. et al. Chemical diversity of metabolites from fungi, cyanobacteria, and plants relative to FDA-approved anticancer agents. ACS Med. Chem. Lett. 3, 645-649 (2012).
17. Sy-Cordero, A. A. et al. Dereplication of macrocyclic trichothecenes from extracts of filamentous fungi through UV and NMR profiles. J. Antibiot. 63, 539-544 (2010).
18. Sica, V. P. et al. Dereplicating and spatial mapping of secondary metabolites from fungal cultures in situ. J. Nat. Prod. 78, 1926-1936 (2015).
19. Zhang, H., Zhang, D., Ray, K. & Zhu, M. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J. Mass Spectrom. 44, 999-1016 (2009).
20. Zhu, M. et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos. 34, 1722-1733 (2006).
21. Xing, J., Zang, M., Zhang, H. & Zhu, M. The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. Anal. Chim. Acta 897, 34-44 (2015).
22. Pähler, A. & Brink, A. Software aided approaches to structure-based metabolite identification in drug discovery and development. Drug Discov. Today Technol. 10, e207-e217 (2013).
23. Sleno, L. The use of mass defect in modern mass spectrometry. J. Mass Spectrom. 47, 226-236 (2012).
24. Ekanayaka, E. A. P., Celiz, M. D. & Jones, A. D. Relative mass defect filtering of mass spectra: a path to discovery of plant specialized metabolites. Plant Physiol. 167, 1221-1232 (2015).
25. Xu, H. et al. Comprehensive qualitative ingredient profiling of Chinese herbal formula Wu-Zhu-Yu decoction via a mass defect and fragment filtering approach using high resolution mass spectrometry. Molecules 21, 664 (2016).
26. Xie, T. et al. Rapid identification of ophiopogonins and ophiopogonones in Ophiopogon japonicus extract with a practical technique of mass defect filtering based on high resolution mass spectrometry. J. Chromatogr. A 1227, 234-244 (2012).
27. El-Elimat, T. et al. High-Resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products. J. Nat. Prod. 76, 1709-1716 (2013).
28. Lu, W., Bennett, B. D. & Rabinowitz, J. D. Analytical strategies for LC-MS-based targeted metabolomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 871, 236-242 (2008).
29. Page, J. S. Ionization and transmission efficiency in an electrospray ionization-mass spectrometry interface. J. Am. Soc. Mass Spectrom 18, 1582-1590 (2007).
30. Liu, F. et al. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3. Cancer Res. 71, 6807-6816 (2011).
31. Paschall, A. V. et al. H3K9 trimethylation silences Fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance. J. Immunol. 195, 1868-1882 (2015).
32. Chen, Y., Miao, Z.-H., Zhao, W.-M. & Ding, J. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11′-dideoxyverticillin-induced G2/M arrest. FEBS Lett. 579, 3683-3690 (2005).
33. Zhang, Y. X. et al. 11,11′Dideoxyverticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity. Anticancer Drugs 16, 515-524 (2005).
34. Figueroa, M. et al. Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J. Antibiot. 65, 559-564 (2012).
35. Li, Z. et al. A novel dereplication strategy for the identification of two new trace compounds in the extract of Gastrodia elata using UHPLC/Q-TOF-MS/MS. J. Chromatogr. B 988, 45-52 (2015).
36. Maslen, S. L., Goubet, F., Adam, A., Dupree, P. & Stephens, E. Structure elucidation of arabinoxylan isomers by normal phase HPLC-MALDI-TOF/TOF-MS/MS. Carbohydr. Res. 342, 724-735 (2007).
37. Schmidt, G. Viscosalines B 1,2 and E 1,2: challenging new 3-alkyl pyridinium alkaloids from the marine sponge Haliclona viscosa. Chem. Eur. J 18, 8180-8189 (2012).
38. Egan, J. M. et al. Antimicrobial fungal endophytes from the botanical medicine goldenseal (Hydrastis canadensis). Phytochem. Lett. 17, 219-225 (2016).
39. Bode, H. B., Bethe, B., Hofs, R. & Zeeck, A. Big effects from small changes: possible ways to explore nature's chemical diversity. Chembiochem. 3, 619-627 (2002).
40. Paguigan, N. D., Raja, H. A., Day, C. S. & Oberlies, N. H. Acetophenone derivatives from a freshwater fungal isolate of recently described Lindgomyces madisonensis (G416). Phytochemistry 126, 59-65 (2016).
41. Abreu, L. M., Moreira, G. M., Ferreira, D., Rodrigues-Filho, E. & Pfenning, L. H. Diversity of Clonostachys species assessed by molecular phylogenetics and MALDI-TOF mass spectrometry. Fungal Biol. 118, 1004-1012 (2014).
42. Raja, H. A. et al. Phylogenetic and chemical diversity of fungal endophytes isolated from Silybum marianum (L) Gaertn. (milk thistle). Mycology 6, 8-27 (2015).
43. Raja, H. A. et al. Minutisphaerales (Dothideomycetes, Ascomycota): a new order of freshwater ascomycetes including a new family, Minutisphaeraceae, and two new species from North Carolina, USA. Mycologia 107, 845-862 (2015).
44. Raja, H. A., Baker, T. R., Little, J. G. & Oberlies, N. H. DNA barcoding for identification of consumer-relevant mushrooms: a partial solution for product certification? Food Chem. 214, 383-392 (2017).
45. Raja, H., Schoch, C. L., Hustad, V., Shearer, C. & Miller, A. Testing the phylogenetic utility of MCM7 in the Ascomycota. MycoKeys 1, 63 (2011).
46. Schroers, H. J. A monograph of Bionectria (Ascomycota, Hypocreales, Bionectriaceae) and its Clonostachys anamorphs. Stud. Mycol. 2001, 1-211 (2002).
47. El-Elimat, T. et al. Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J. Nat. Prod. 77, 2088-2098 (2014).
48. Kaur, A. et al. New diketopiperazine dimer from a filamentous fungal isolate of Aspergillus sydowii. Magn. Reson. Chem. 53, 616-619 (2015).